Screener
Edwards Lifesciences EW EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Edwards Lifesciences’s 8-K, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:29 PM EDT
- Accession
- 0001099800-26-000038
FAQ
- What is Edwards Lifesciences's EPS (basic)?
- Edwards Lifesciences (EW) reported EPS (basic) of $0.42 in Q2 2026.
- How has Edwards Lifesciences's EPS (basic) changed year-over-year?
- Edwards Lifesciences's EPS (basic) decreased by 26.3% year-over-year, from $0.57 to $0.42.
- What is the long-term trend for Edwards Lifesciences's EPS (basic)?
- Over 4 years (2021 to 2025), Edwards Lifesciences's EPS (basic) has grown at a -6.6% compound annual growth rate (CAGR), from $2.42 to $1.84.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Edwards Lifesciences's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude